Thu, November 10, 2022
Wed, November 9, 2022
Tue, November 8, 2022
Mon, November 7, 2022

Matthew Harrison Maintained (BNTX) at Hold with Increased Target to $203 on, Nov 8th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-203-on-nov-8th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Matthew Harrison of Morgan Stanley, Maintained "BioNTech SE" (BNTX) at Hold with Increased Target from $194 to $203 on, Nov 8th, 2022.

Matthew has made no other calls on BNTX in the last 4 months.



There are 3 other peers that have a rating on BNTX. Out of the 3 peers that are also analyzing BNTX, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Jessica Fye of "JP Morgan" Maintained at Hold with Decreased Target to $132 on, Monday, October 24th, 2022


These are the ratings of the 2 analyists that currently disagree with Matthew


  • Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $272 on, Wednesday, August 10th, 2022
  • Daina Graybosch of "SVB Leerink" Maintained at Buy with Increased Target to $224 on, Friday, July 29th, 2022

Publication Contributing Sources